Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

LON/0M2O stock hub

LON/0M2O has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0M2Ois not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.3B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0M2O

In the news

Latest news · LON/0M2O

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.9

P25 n/aP50 n/aP75 n/a

Trailing P/E18

P25 n/aP50 n/aP75 n/a

ROE48.4

P25 n/aP50 n/aP75 n/a

ROIC39.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0M2O market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

EUR

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	UK
Employees	4,132
Employees Change	149%
Employees Change Percent	3.84
Enterprise value	EUR 8.5B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Isin	FI0009014377
Last refreshed	2026-05-10
Market cap	EUR 8.3B
Price	EUR 69.2
Price currency	EUR
Rev Per Employee	412,623.97x
Sic	2834
Symbol	lon/0M2O
Website	https://www.orionpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.54%
EV Earnings	18.29x
EV/EBIT	14.63x
EV/EBITDA	13.46x
EV/FCF	48.4x
EV/Sales	5.01x
FCF yield	2.09%
Forward P/E	15.87x
P/B ratio	8.51x
P/E ratio	18.04x
P/S ratio	4.89x
PE Ratio10 Y	22.42x
PE Ratio3 Y	22.5x
PE Ratio5 Y	23.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.25%
EBITDA Margin	36.91%
FCF margin	10.24%
Gross margin	64.8%
Gross Profit	EUR 1.1B
Gross Profit Growth	29.42%
Gross Profit Growth Q	25.87%
Gross Profit Growth3 Y	14.51%
Gross Profit Growth5 Y	15.17%
Net Income	EUR 462.3M
Net Income Growth	52.39%
Net Income Growth Q	47.47%
Net Income Growth3 Y	16.36%
Net Income Growth5 Y	20.07%
Pretax Margin	34.02%
Profit Margin	27.11%
Profit Per Employee	EUR 111,873
ROA	22.11
Roa5y	16.95
ROCE	52.22
ROE	48.36
Roe5y	34.21
ROIC	39.73
Roic5y	35.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.76%
Cagr15y	14.71%
Cagr1y	26.57%
Cagr3y	20.45%
Cagr5y	16.98%
Div CAGR10	3.77%
Div CAGR3	1.78%
Div CAGR5	3.05%
EPS Growth	52.06
EPS Growth Q	46.74
EPS Growth3 Y	16.29
EPS Growth5 Y	20.17
FCF Growth	-1.04%
FCF Growth Q	-67.5%
FCF Growth3 Y	-16.6%
FCF Growth5 Y	-4.43%
OCF Growth	5.98%
OCF Growth Q	-52.2%
OCF Growth10 Y	1.23%
OCF Growth3 Y	-11.96%
OCF Growth5 Y	-0.51%
Revenue Growth	22.92x
Revenue Growth Q	17.8x
Revenue Growth3 Y	13.15x
Revenue Growth5 Y	12.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.03
Assets	EUR 1.8B
Cash	EUR 174M
Current Assets	EUR 1.2B
Current Liabilities	EUR 690.8M
Debt	EUR 288.4M
Debt EBITDA	EUR 0.45
Debt Equity	EUR 0.29
Debt FCF	EUR 1.65
Equity	EUR 980.1M
Interest Coverage	77.76
Liabilities	EUR 835.4M
Long Term Assets	EUR 594.7M
Long Term Liabilities	EUR 144.6M
Net Cash	EUR -114.4M
Net Cash By Market Cap	EUR -1.37
Net Debt EBITDA	EUR 0.18
Net Debt Equity	EUR 0.12
Net Debt FCF	EUR 0.66
Tangible Book Value	EUR 814.8M
Tangible Book Value Per Share	EUR 5.78
WACC	5.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.77
Inventory Turnover	1.45
Net Working Capital	EUR 552.7M
Quick ratio	1.13
Working Capital	EUR 534.9M
Working Capital Turnover	EUR 2.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.1%
Dividend Growth	8.66%
Dividend Growth Years	1%
Dividend per share	EUR 1.49
Dividend Years	19
Dividend Yield	2.15%
Ex Div Date	2026-03-25
Last Dividend	EUR 0.78
Payout Frequency	Semi-Annual
Payout Ratio	43.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	232.19%
1Y total return	26.55%
200-day SMA	66.97
3Y total return	74.77%
50-day SMA	69.77
50-day SMA vs 200-day SMA	50over200
5Y total return	119.04%
All Time High	75.4
All Time High Change	-8.22%
All Time High Date	2026-02-12
All Time Low	10.37
All Time Low Change	567.31%
All Time Low Date	2009-03-30
ATR	1.77
Beta	0.27
Ch YTD	8.29
High	69.45
High52	75.4
High52 Date	2026-04-21
High52ch	-8.22%
Low	68.25
Low52	51.8
Low52 Date	2025-05-12
Low52ch	33.59%
Ma50ch	-0.81%
Price vs 200-day SMA	3.34%
RSI	45.8
RSI Monthly	65.15
RSI Weekly	52.41
Sharpe ratio	0.82x
Sortino ratio	1.35
Total Return	2.05%
Tr YTD	9.76
Tr15y	683.17%
Tr1m	-3.27%
Tr1w	0.16%
Tr3m	-3.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 583.9M
Operating Income Growth	40.28
Operating Income Growth Q	47.43
Operating Income Growth3 Y	16.51
Operating Income Growth5 Y	19.86
Operating margin	34.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	123,112,532%
Net Borrowing	-2,595,095.1
Shares Insiders	8.75%
Shares Institutions	38.68%
Shares Qo Q	-0.05%
Shares Yo Y	0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 174.6M
Average Volume	29,260.25x
Bv Per Share	6.96
CAPEX	EUR -66.7M
Ch10y	132
Ch15y	307.4
Ch1m	-3.27
Ch1w	0.16
Ch1y	23.38
Ch3m	-5.16
Ch3y	61.31
Ch5y	87.74
Ch6m	21.72
Change	-1.42%
Change From Open	0.07
Close	70.2
Days Gap	-1.5
Depreciation Amortization	45,068,150.9
Dollar Volume	1,458,528.4
Earnings Date	2026-04-23
EBIT	EUR 583.9M
EBITDA	EUR 629.4M
EPS	EUR 3.28
F Score	6
FCF	EUR 174.6M
FCF EV Yield	2.07x
Financing CF	-204,323,037
Fiscal Year End	December
Founded	1,917
Goodwill	75,430,763.2
Graham Number	26.49177
Graham Upside	-61.72
Income Tax	EUR 117.8M
Investing CF	-89,587,793
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Lynch Fair Value	EUR 77
Lynch Upside	11.27
Ma150	66.73
Ma150ch	3.71%
Ma20	70.82
Ma20ch	-2.29%
Net CF	-52,477,840
Next Earnings Date	2026-07-17
Open	69.15
P FCF Ratio	47.76
P OCF Ratio	34.56
Payment Date	2026-04-02
Position In Range	79.17
Ppne	396,357,519.3
Price Date	2026-05-08
Price EBITDA	EUR 13.25
Ptbv Ratio	10.24
Relative Volume	0.71x
Revenue	1,704,962,231x
Tax By Revenue	6.91x
Tax Rate	20.31%
Tr6m	23.37%
Volume	21,077
Z Score	8.69

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0M2O dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$1.49 annual per share

Payout ratio

+43.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.0%

1 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2026-03-25

Performance

LON/0M2O stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0M2O?

Insider, institutional, and short-interest positioning.

Institutional ownership

+38.7%

Share of float held by funds and institutions

Insider ownership

+8.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

LON/0M2O momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.8

Neutral momentum band

Price vs 200-day MA

+3.3%

50/200-day relationship not available

Beta (5Y)

0.27

Less volatile than the market

Sharpe ratio

0.82

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0M2O

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0M2O stock rating?

lon/0M2O is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0M2O analysis?

The full report lives at /stocks/lon/0M2O/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0M2O?

The latest report frames lon/0M2O around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0M2O page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.